Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer

Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer

Long non-coding RNAs (lncRNAs) have been shown to participate in the development and progression of several different types of cancer. Past studies indicated that lncRNA MAFG-antisense 1 (AS1) promotes colorectal cancer. However, the role of MAFG-AS1 in hepatocellular carcinoma (HCC) remains unclear...

Full description

Bibliographic Details
Main Authors:	Tianming Chen, Bin Huang, Yaozhen Pan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	long non-coding RNA MAFG-AS1 miR-3196 STRN4 liver cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.688603/full

Similar Items

The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population
by: Zhang L, et al.
Published: (2021-04-01)

The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population [Corrigendum]
by: Zhang L, et al.
Published: (2021-12-01)

A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2
by: Olga Vera, et al.
Published: (2021-03-01)

LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis
by: Qian C, et al.
Published: (2020-08-01)

LncRNA MAFG-AS1 is involved in human cancer progression
by: Penghui Li, et al.
Published: (2023-11-01)

LncRNA NEAT1/miR-146a-5p Axis Restores Normal Angiogenesis in Diabetic Foot Ulcers by Targeting mafG
by: TCA Architha, et al.
Published: (2024-03-01)

Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis
by: Guangyao Lin, et al.
Published: (2023-12-01)

Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers
by: Zhiyu Huang, et al.
Published: (2023-07-01)

STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
by: Yichao Zhang, et al.
Published: (2022-01-01)

Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196
by: Georg Sebastian Hönes, et al.
Published: (2022-11-01)

Deficiency of the bZIP transcription factors Mafg and Mafk causes misexpression of genes in distinct pathways and results in lens embryonic developmental defects
by: Shaili D. Patel, et al.
Published: (2022-08-01)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
by: Peizhang Li, et al.
Published: (2022-08-01)

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
by: Linlin Zhang, et al.
Published: (2022-09-01)

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib
by: Guo-qiang Song, et al.
Published: (2023-09-01)

Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
by: Lucheng Zhu, et al.
Published: (2022-11-01)

Primary resistance to alectinib in a patient with STRN‐ALK‐positive non‐small cell lung cancer: A case report
by: Kunyan Sun, et al.
Published: (2021-06-01)

Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion
by: XiaoQing Li, et al.
Published: (2023-10-01)

Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile
by: Yuanyuan Tian, et al.
Published: (2022-05-01)

Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy
by: Ruihe Lin, et al.
Published: (2023-10-01)

MAFG‐AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma
by: Mengqing Xiao, et al.
Published: (2020-12-01)

STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells
by: Astrid Murumägi, et al.
Published: (2021-04-01)

Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review)
by: Amber Xinyu Li, et al.
Published: (2023-12-01)

Coexistence of a novel STRN-ALK, NBEA-ALK double-fusion in an ovarian malignant mesothelioma patient: a case report and review
by: Xiao Wu, et al.
Published: (2023-04-01)

Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8
by: Zhiyan Ruan, et al.
Published: (2020-10-01)

CircStrn3 targeting microRNA-9-5p is involved in the regulation of cartilage degeneration and subchondral bone remodelling in osteoarthritis
by: Bin Li, et al.
Published: (2023-01-01)

miR‐138 and miR‐193 target long non‐coding RNA UCA1 to inhibit cell proliferation, migration, and invasion of lung cancer
by: Guangsu Xun, et al.
Published: (2020-09-01)

When Oxidative Stress Meets Epigenetics: Implications in Cancer Development
by: Álvaro García-Guede, et al.
Published: (2020-06-01)

Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation
by: Hao Zhang, et al.
Published: (2022-07-01)

miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells
by: Lantang Huang, et al.
Published: (2022-11-01)

MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1
by: Xiao-Jun Xiang, et al.
Published: (2015-07-01)

LINC01287 facilitates proliferation, migration, invasion and EMT of colon cancer cells via miR-4500/MAP3K13 pathway
by: Dazhi Fu, et al.
Published: (2021-07-01)

LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319 / Snail1
by: Wei Guo, et al.
Published: (2021-08-01)

CircPDSS1 promotes the proliferation, invasion, migration, and EMT of breast cancer cell via regulating miR-320c/CKAP5 axis
by: Xia Liu, et al.
Published: (2022-07-01)

Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis
by: Fei-Yu Chen, et al.
Published: (2020-10-01)

The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382
by: Liang Zhao, et al.
Published: (2017-08-01)

miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1
by: Zhihui Wang, et al.
Published: (2019-04-01)

miR-636 inhibits EMT, cell proliferation and cell cycle of ovarian cancer by directly targeting transcription factor Gli2 involved in Hedgehog pathway
by: Jiong Ma, et al.
Published: (2021-01-01)

MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6
by: Kegan Zhu, et al.
Published: (2016-05-01)

Retracted: Demethylation of miR‐195 suppresses prostate cancer cell proliferation, migration and invasion
by: Xiaokun Ma, et al.
Published: (2020-04-01)

miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
by: Rui Suzuki, et al.
Published: (2018-10-01)